Impact of a tailored exercise program on prostate cancer patients treated with androgen deprivation therapy: A pilot interventional study in the Australian regional setting
Not Applicable
Not yet recruiting
- Conditions
- Prostate cancer
- Registration Number
- ACTRN12618000853246
- Lead Sponsor
- Dr Michael Kwok (Principal Investigator)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not yet recruiting
- Sex
- Male
- Target Recruitment
- 12
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie exercise-induced improvements in prostate cancer patients on androgen deprivation therapy?
How does a tailored exercise program compare to standard-of-care interventions in managing prostate cancer treatment side effects?
Are there specific biomarkers that predict response to exercise interventions in prostate cancer patients undergoing androgen deprivation therapy?
What are the known adverse events associated with exercise programs in prostate cancer patients and how can they be managed?
What combination approaches or alternative therapies are being explored alongside androgen deprivation therapy for prostate cancer in clinical trials?